http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102918056-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3120ae9cab5bb4831f0cc16288966367
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26
filingDate 2011-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a49163a95e7a575938eb52bb8b9d668b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12f54402b66621acbe183c5d70bd9ea8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1d4af99aa5432aa5c4be8802be55a03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff26d3bf23456ab350f7e29b116015d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64b6310b715a10c7152b4c34e157d25e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d66059caa231bbb0f3976a0b06d6067
publicationDate 2013-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102918056-A
titleOfInvention New Glucagon Analogs
abstract The present invention relates to novel peptide compounds having a prolonged profile of action and improved solubility and stability, to the use of said compounds in therapy, to methods of treatment comprising administering said compounds to a patient in need thereof, and to said Use of the compound in the preparation of medicaments. The compounds of the invention are of particular interest for the treatment of hyperglycemia, diabetes and obesity and various diseases or conditions associated with hyperglycemia, diabetes and obesity.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105307672-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108261391-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108261391-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108261544-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105307672-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105793282-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11053317-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107108713-A
priorityDate 2010-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0069900-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002049153-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467459005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163556157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467786175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467708053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467799580
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466469358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466303852
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467996963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467783410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467482477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465149242

Total number of triples: 53.